Clinical Trial: A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06941480) titled 'A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate' on April 16.

Brief Summary: The purpose of this study is to find out whether 177Lu-DTPA-SC16.56 is a safe treatment for people with small-cell lung cancer or neuroendocrine prostate cancer

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Neuroendocrine Tumor of the Lung Neuroendocrine Carcinoma of Lung Neuroendocrine Carcinoma Neuroendocrine Carcinoma of Prostate

Intervention: DIAGNOSTIC_TEST: PET/CT

Participants will undergo 89Zr-DFO-SC16.56 Ab PET/CT

BIOLOGICAL: 177Lu-DTPA-SC16.56

177Lu-DTPA-SC16.56, to be ad...